Brief: Jenny Sundqvist Appointed New CEO Of InDex Pharmaceuticals
Oct 10 (Reuters) - InDex Pharmaceuticals Holding AB
INDEX.ST :
* JENNY SUNDQVIST NEW CEO OF INDEX PHARMACEUTICALS
* JOHAN GILÉUS, WHO HAS BEEN ACTING CEO SINCE APRIL 2022,
WILL
CONTINUE AS CFO IN COMPANY
* JENNY SUNDQVIST WILL TAKE OVER AS CEO FROM JANUARY 1, 2023
Source text for Eikon: ID:nWkr45bDf
Further company coverage: INDEX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen